A previous study of more than 500 melanoma patients has revealed that strong cytoplasmic ATF2 expression is associated with primary specimens and better survival, whereas strong nuclear ATF2 expression is associated with metastatic specimens and poor survival [29]. This evidence concerns the gene ATF2 and melanoma.